Fund II: Investing in the Future of Health
Strategy
Our thesis on health outcomes investing
We invest in founders who've lived the problem—clinical backgrounds, personal health journeys, deep domain expertise. They build platforms that deliver health outcomes to employers, payers, and health systems. Fund I validated execution. Fund II narrows focus to health outcomes.
Lived experience
Founders with clinical training and personal stakes in solving health
Proven traction
MDisrupt's $1M AHA investment shows buyers are ready to commit
Timing
The market is ready for health solutions
Prevention has moved from theory to practice. Payers now fund what works, and employers are buying directly. The conditions exist for real change.
65%
Large employers buying direct
40%
Pre-seed valuations down
100%
Outcomes contracts at scale
Proven
Payers funding prevention now
Ready to explore the opporunity?
Fund II is open to accredited investors who believe prevention is the next frontier in health. If the thesis resonates, we'd love to connect directly.